Table 1 Baseline characteristics.

From: Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control

Characteristics

Value

Sex (male/female)

19/14

Age (years)

64.1 ± 12.3

Duration of hypertension (year)

7.96 ± 6.04

Systolic blood pressure (mmHg)

140.5 ± 13.2

Diastolic blood pressure (mmHg)

80.8 ± 11.0

Smoking history (%)

45.5%

Serum creatinine (mg/dL)

2.07 ± 1.01

Blood urea nitrogen (mg/dL)

35.1 ± 14.9

eGFR (mL/min/1.73m2)

31.0 ± 14.9

Urine protein (mg/dL)

118.0 ± 122.8

Estimated quantitative proteinuria (g/g Cr)a

1.62 ± 1.74

MR-proADM concentration (ng/mL)

2.99 ± 1.85

Treatment intensity score

2.11 ± 1.07

Primary disease of CKD

IgA nephropathy

10

Nephrosclerosis

9

Diabetic nephropathy

3

Membranous nephropathy

3

Lupus erythematosus nephritis

2

Others

6

Medical history of diabetes

18

  1. eGFR estimated glomerular filtration rate, Cr creatinine, MR-proADM mid-regional pro-adrenomedullin, CKD chronic kidney disease.
  2. aEstimated quantitative proteinuria was calculated as urine protein to creatinine ratio.
Back to article page